Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150190 | SCV000197111 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Ala90Ala in exon 2 of BLOC1S3: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 12.6% (211/1680) of African American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs758506). |
Prevention |
RCV000150190 | SCV000317276 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000150190 | SCV000343727 | benign | not specified | 2016-07-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001519342 | SCV001728195 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554235 | SCV001775466 | benign | Hermansky-Pudlak syndrome 8 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001519342 | SCV001909722 | benign | not provided | 2018-11-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001519342 | SCV005310351 | benign | not provided | criteria provided, single submitter | not provided |